Showing results (471-480 of 567) with videos related to

Sort By:
Pageof 57
Diabetes, Obesity & Metabolism|July 26, 2024
Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors for the treatment of diabetes mellitus in liver transplant recipientsKatina Zheng, Amirhossein Azhie, Xiaoting You, et al.
BMJ Open|March 29, 2024
Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma: a multicentre retrospective cohort studySoumaya Labidi, Nicholas Meti, Reeta Barua, et al.
European Urology Oncology|June 16, 2019
Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 TrialsMarco Bandini, Alberto Briganti, Elizabeth R Plimack, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 29, 2017
HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cellsKrisha Desai, Radhika Aiyappa, Jyothi S Prabhu, et al.
European Urology Oncology|July 17, 2019
Efficacy of Surgery in the Primary Tumor Site for Metastatic Urothelial Cancer: Analysis of an International, Multicenter, Multidisciplinary DatabaseMarco Moschini, Evanguelos Xylinas, Stefania Zamboni, et al.
ESMO Open|March 19, 2025
Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in older patientsS Gupta, M A Climent Duran, S S Sridhar, et al.
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|May 24, 2017
Clinical Utility of Gallium-68 PSMA PET/CT Scan for Prostate CancerKumaraswamy G Kallur, Prashanth G Ramachandra, Krishnappa Rajkumar, et al.
Global Health, Science and Practice|October 1, 2021
Care Around Birth Approach: A Training, Mentoring, and Quality Improvement Model to Optimize Intrapartum and Immediate Postpartum Quality of Care in IndiaGunjan Taneja, Enisha Sarin, Devina Bajpayee, et al.
Investigational New Drugs|May 19, 2015
A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195B J Eigl, S North, E Winquist, et al.
Translational Oncology|July 14, 2017
Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage DiseaseJyothi S Prabhu, Aruna Korlimarla, C E Anupama, et al.
Pageof 57